Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-06-12

Clinical Trial Update: Association of Multiple Genetic Polymorphisms With Clozapine-Associated Metabolic Change in Schizophrenia

View source ↗

Summary

This clinical trial update investigates whether multiple genetic polymorphisms influence metabolic changes seen in schizophrenia patients treated with clozapine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

Sponsor: Seoul National Hospital | Conditions: Schizophrenia, Metabolic Syndrome | Status: UNKNOWN